Cutaneous effects after prolongaded use of hydroxyurea in Polycythemia Vera.
نویسندگان
چکیده
Hydroxyurea is an hydroxylated urea derivative used in many myeloproliferative disorders. Many, but unusual cutaneous disorders are related after its prolonged use. Their pathogenesis is not clear, but it is suggested that there is direct toxicity of the drug on the skin. We described a white, 75-year old man with diagnosis of Polycythemia Vera that in 11 years of treatment developed many cutaneous lesions: skin hyperpigmentation, atrophic lesions on forearms, longitudinal melanonychia of 20 nails, right forearm ulcer, cutaneous xerosis, ichthyosis and auricular spinocellular carcinoma. At this moment, the literature reports describe little diversity of lesions in affected patients.
منابع مشابه
Cutaneous T-Cell Lymphoma after Polycythemia Vera: An Iranian Case Report
Concomitant polycythemia vera (PV) and primary cutaneous T-cell lymphomas (CTCL) is very rare. In this report, we describe a patient who developed CTCL after PV, receiving long-term hydroxyurea for PV. The patient referred with large Erythematous patches and plaques on back, flanks and legs. The pathology report showed CTCL. Also, the case had had PV since twenty years ago with phlebotomy as th...
متن کاملFrequent reduction or absence of detection of the JAK2-mutated clone in JAK2V617F-positive patients within the first years of hydroxyurea therapy.
We analyzed the effect of hydroxyurea on the JAK2V617F allelic ratio (%JAK2V617F), measured in purified blood granulocytes, of patients with polycythemia vera and essential thrombocythemia. Thirty-six patients were examined sequentially prior to and after start of hydroxy-urea therapy (8 polycythemia vera, 17 essential thrombocythemia), or while remaining untreated (2 polycythemia vera, 9 essen...
متن کاملChorea disclosing a polycythemia vera
Chorea is a rare complication of polycythemia. We report the case of a 70 year-old woman whose polycythemia vera (PV), with Janus Kinase-2 (JAK2) mutation, presented as chorea. Chorea resolved quickly after hydroxyurea therapy.
متن کاملAutologous bone marrow transplantation in chronic myeloid leukaemia.
1. Najean Y, Rain JD, Billotey C. Epidemiological data in polycythaemia vera: a study of 842 cases. Hematol Cell Ther 1998; 40:159-65. 2. Fernandez-Luna JL, Silva M, Richard C, Sanz C, Benito A. Pathogenesis of polycythemia vera. Haematologica 1998; 83:150-8. 3. Barosi G. Pathogenesis of polycythemia vera: do we have the right pieces to the puzzle? Haematologica 1998; 83:97-8. 4. Barbui T, Fina...
متن کاملSafety profile of hydroxyurea in the treatment of patients with Philadelphia-negative chronic myeloproliferative disorders.
The efficacy of hydroxyurea (HU) in myeloproliferative disorders is well documented. HU controls thrombocytosis both in polycythemia vera (PV) and in essential thrombocythemia (ET), while reducing the risk of thrombosis.1 Despite many anectodal reports, no evaluation of the prevalence and type of side effects of HU exists in large series of patients.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Anais brasileiros de dermatologia
دوره 86 4 شماره
صفحات -
تاریخ انتشار 2011